Video: Views and voices on creating the Marathon of Hope Cancer Centres

PM2 CAN-IMPACT-IO a national immunotherapy biospecimen collection study has now opened

PM2 CAN-IMPACT-IO is a unique national initiative to measure, predict and assess cancer treatment outcomes in patients who have been treated with immunotherapy. Patients on CCTG clinical trials who co...

Our Network reaches new heights! A letter from Dr. André Veillette

Dr. André Veillette, Executive Director of the MOHCCN, provides an update on the exciting achievement from across our Network.

Network names four outstanding early-career clinician-scientists as recipients of its 2024 MOHCCN Clinician-Scientist Awards

Four promising, early-career clinician-scientists from Alberta, Ontario and Quebec have been named recipients of the 2024 Clinician-Scientist Awards, funded by the Marathon of Hope Cancer Centres Netw...

Network names 10 early-career data scientists as recipients of its 2024 Health Informatics & Data Science Awards

Each will receive $40,000 from the Network over the next year to be matched by their host institutions for a total of $80,000 to support groundbreaking research in precision oncology.